Scientists build heart cells in a dish to unravel genetic heart disease

NCT ID NCT02413450

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study collects blood or skin samples from 100 adults with inherited heart rhythm disorders (like Long QT Syndrome or Brugada Syndrome) and healthy volunteers. Researchers will turn these samples into stem cells and then into heart cells to study how these diseases work and test potential treatments in the lab. The goal is to better understand these conditions, not to directly treat participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could lead to better understanding of inherited heart diseases and help test new treatments in the lab.
What could go wrong
This is an early-stage research study, not a treatment trial. It may not directly lead to new therapies, and lab models may not fully replicate human disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC CARDIOMYOPATHY (AC, ARVD/C) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins Medical Institute

    Baltimore, Maryland, 21287-9106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.